RECURRENT THYMIC CARCINOMA

Clinical trials for RECURRENT THYMIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT THYMIC CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for rare chest cancer? trial tests adding a targeted drug to chemo

Disease control Completed

This study tested if adding a targeted drug called ramucirumab to standard chemotherapy (carboplatin and paclitaxel) works better for people with advanced thymic cancer that cannot be removed by surgery. It involved 21 patients who were randomly assigned to receive either the sta…

Matched conditions: RECURRENT THYMIC CARCINOMA

Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

RECURRENT THYMIC CARCINOMA

Get alerted when new RECURRENT THYMIC CARCINOMA trials appear

New hope for rare chest cancer? trial tests adding a targeted drug to chemo